TY - JOUR
T1 - The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation
AU - Keshavjee, S. H.
AU - Yamazaki, F.
AU - Yokomise, H.
AU - Cardoso, P. F.
AU - Mullen, J. B.M.
AU - Slutsky, A. S.
AU - Patterson, G. A.
N1 - Funding Information:
From the Department of Surgery, Harbor General Hospital,* Torrance, California, UCLA School of Medicine,I-and Division of Biostatistics, UCLA School of Public Health,** Los Angeles, CaJifornia. This project was supported, in part, by Grant #HS 01833 from the National Center for Health Services, Health Resources Administration. Address for reprints: William C. Shoemaker, MD, Department of Surgery, Harbor General Hospital, 1000 W. Carson Street, Torrance, Califomia 90509.
PY - 1992
Y1 - 1992
N2 - We have previously demonstrated that a low-potassium dextran solution provides superior and more reliable preservation of lungs for 12 hours than that provided by the commonly used Euro-Collins solution. This study was designed to examine the individual contributions of dextran 40 and a low (extracellular) potassium concentration to lung preservation. In a randomized, blinded study using an in vivo canine single-lung transplant model, lungs preserved with low-potassium dextran solution (K+, 4 mmol/L; dextran 40, 20 gm/L) were compared to lungs preserved with low-potassium, no- dextran solution (K+, 4 mmol/L) and high-potassium dextran solution (K+, 123 mmol/L; dextran 40, 20 gm/L). The lungs were assessed immediately and 3 days after transplantation. The low-potassium dextran solution provided excellent immediate pulmonary function with little variability (arterial oxygen tension, 519 ± 12 mm Hg, measured on the transplanted lung alone, inspired oxygen fraction = 1.0, n = 6). Removing the dextran 40 from the flush solution (low-potassium group) led to a significant deterioration in pulmonary function (arterial oxygen tension, 243 ± 78 mm Hg, n = 6, p < 0.01). The high-potassium dextran solution provided extremely poor preservation (arterial oxygen tension, 176 ± 79 mm Hg; n = 6; p < 0.01). Two animals in this group died within 6 hours of operation. Viability of the transplanted bronchus was significantly improved with the two solutions containing dextran 40. These results indicate that dextran 40 and low potassium concentration both contribute significantly to the uniformly excellent 12-hour lung preservation seen with the low-potassium dextran solution.
AB - We have previously demonstrated that a low-potassium dextran solution provides superior and more reliable preservation of lungs for 12 hours than that provided by the commonly used Euro-Collins solution. This study was designed to examine the individual contributions of dextran 40 and a low (extracellular) potassium concentration to lung preservation. In a randomized, blinded study using an in vivo canine single-lung transplant model, lungs preserved with low-potassium dextran solution (K+, 4 mmol/L; dextran 40, 20 gm/L) were compared to lungs preserved with low-potassium, no- dextran solution (K+, 4 mmol/L) and high-potassium dextran solution (K+, 123 mmol/L; dextran 40, 20 gm/L). The lungs were assessed immediately and 3 days after transplantation. The low-potassium dextran solution provided excellent immediate pulmonary function with little variability (arterial oxygen tension, 519 ± 12 mm Hg, measured on the transplanted lung alone, inspired oxygen fraction = 1.0, n = 6). Removing the dextran 40 from the flush solution (low-potassium group) led to a significant deterioration in pulmonary function (arterial oxygen tension, 243 ± 78 mm Hg, n = 6, p < 0.01). The high-potassium dextran solution provided extremely poor preservation (arterial oxygen tension, 176 ± 79 mm Hg; n = 6; p < 0.01). Two animals in this group died within 6 hours of operation. Viability of the transplanted bronchus was significantly improved with the two solutions containing dextran 40. These results indicate that dextran 40 and low potassium concentration both contribute significantly to the uniformly excellent 12-hour lung preservation seen with the low-potassium dextran solution.
UR - http://www.scopus.com/inward/record.url?scp=0026604302&partnerID=8YFLogxK
U2 - 10.1016/s0022-5223(19)35033-0
DO - 10.1016/s0022-5223(19)35033-0
M3 - Article
C2 - 1370970
AN - SCOPUS:0026604302
SN - 0022-5223
VL - 103
SP - 314
EP - 325
JO - Journal of Thoracic and Cardiovascular Surgery
JF - Journal of Thoracic and Cardiovascular Surgery
IS - 2
ER -